The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis

References

• Abella V, Scotece M, Conde J, Gómez R, Lois A, Pino J. 2015. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 20:565–571.
   PubMed Web of Science ®Google Scholar
• American Society for Reproductive Medicine (ASRM). 1997. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertility and Sterility 67:817–821.
   PubMed Web of Science ®Google Scholar
• Becker CM, Louis G, Exarhopoulos A, Mechsner S, Ebert AD, Zurakowski D, et al. 2010. Matrix metalloproteinases are elevated in the urine of patients with endometriosis. Fertility and Sterility 94:2343–2346.
   PubMed Web of Science ®Google Scholar
• Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. 1997. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. Journal of Clinical Investigation 99:2851–2857.
   PubMed Web of Science ®Google Scholar
• Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, et al. 2002. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertility and Sterility 78:787–795.
   PubMed Web of Science ®Google Scholar
• Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M. 2001. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertility and Sterility 75:152–159.
   PubMed Web of Science ®Google Scholar
• Collette T, Maheux R, Mailloux J, Akoum A. 2006. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Human Reproduction (Oxford, England) 21:3059–3067.
   PubMed Web of Science ®Google Scholar
• Cymbaluk-Płoska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Chudecka K, Bulsa M, et al. 2017. Clinical relevance of NGAL/MMP-9 pathway in patients with endometrial cancer. Disease Markers 2017:6589262. doi:10.1155/2017/6589262
   PubMed Web of Science ®Google Scholar
• De Sanctis P, Elmakky A, Farina A, Caramelli E, Seracchioli R, Mabrouk M, et al. 2011. Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. Gynecologic and Obstetric Investigation 71:118–123.
   PubMed Web of Science ®Google Scholar
• Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. 2014. ESHRE guideline: management of women with endometriosis. Human Reproduction (Oxford, England) 29:400–412.
   PubMed Web of Science ®Google Scholar
• Hirsch M, Duffy J, Davis CJ, Nieves Plana M, Khan KS, International Collaboration to Harmonise Outcomes and Measures for Endometriosis. 2016. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis. BJOG: An International Journal of Obstetrics and Gynaecology 123:1761–1768.
   PubMed Web of Science ®Google Scholar
• Huang HF, Hong LH, Tan Y, Sheng JZ. 2004. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertility and Sterility 81:1235–1239.
   PubMed Web of Science ®Google Scholar
• Liao CJ, Li PT, Lee YC, Li SH, Chu ST. 2013. Lipocalin 2 induces the epithelial-mesenchymal transition in stressed endometrial epithelial cells: possible correlation with endometriosis development in a mouse model. Reproduction 20147:179–187.
   Google Scholar
• Liu H, Wang J, Wang H, Tang N, Li Y, Zhang Y, et al. 2015. Correlation between matrix metalloproteinase-9 and endometriosis. International Journal of Clinical and Experimental Pathology 8:13399–13404.
   PubMed Web of Science ®Google Scholar
• Long L, Cao Y, Tang L. 2012. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression. International Journal of Gynecological Cancer 22:539–545.
   PubMed Web of Science ®Google Scholar
• Mei J, Jin LP, Ding D, Li MQ, Li DJ, Zhu XY. 2012. Inhibition of IDO1 suppresses cyclooxygenase-2 and matrix metalloproteinase-9 expression and decreases proliferation, adhesion and invasion of endometrial stromal cells. Molecular Human Reproduction 18:467–476.
   PubMed Web of Science ®Google Scholar
• Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, et al. 2016. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database of Systematic Reviews 1:CD012179.
   Google Scholar
• Nisenblat V, Prentice L, Bossuyt PM, Farquhar C, Hull ML, Johnson N. 2016. Combination of the non-invasive tests for the diagnosis of endometriosis. Cochrane Database of Systematic Reviews 7:CD012281.
   PubMed Web of Science ®Google Scholar
• Ria R, Loverro G, Vacca A, Ribatti D, Cormio G, Roccaro AM, et al. 2002. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. European Journal of Clinical Investigation 32:199–206.
   PubMed Web of Science ®Google Scholar
• Sharpe-Timms KL, Zimmer RL, Jolliff WJ, Wright JA, Nothnick WB, Curry TE. 1998. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertility and Sterility 69:916–923.
   PubMed Web of Science ®Google Scholar
• Sillem M, Prifti S, Koch A, Neher M, Jauckus J, Runnebaum B. 2001. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 95:167–174.
   PubMed Web of Science ®Google Scholar
• Szamatowicz J, Laudański P, Tomaszewska I. 2002. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Human Reproduction (Oxford, England) 17:284–288.
   PubMed Web of Science ®Google Scholar
• Wykes CB, Clark TJ, Khan KS. 2004. Accuracy of laparoscopy in the diagnosis of endometriosis: a systematic quantitative review. BJOG: An International Journal of Obstetrics & Gynaecology 111:1204–1212.
   PubMed Web of Science ®Google Scholar